Anaerobic PerformanceNCT07797205
Pre-Exercise Hyperventilation Effects on Wingate Test
A study testing Pre-exercise Voluntary Hyperventilation in people with Anaerobic Performance, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).
Trial summary
This study investigates the acute effects of pre-exercise voluntary hyperventilation on pulmonary gas exchange, cardiovascular responses, and anaerobic performance during a 30-second Wingate test in athletic males using a randomized crossover design. Read more about this study
- Who is it for?
- Ages 18 to 26 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Anaerobic Performance
- What is being tested?
- Pre-exercise Voluntary Hyperventilation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 11 Feb 2026to 25 Feb 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 26 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Being a healthy male competitive athlete aged 18-26 years
- Having at least three years of consistent anaerobic training experience
- Being a nonsmoker
Who cannot join
- Having any cardiovascular, musculoskeletal, neurological, or pulmonary disorders
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Manisa Celal Bayar University, Faculty of Sport Sciences
Manisa, 45040
About this study
Official title: Acute Effects of Pre-Exercise Voluntary Hyperventilation on Ventilatory Kinetics and Anaerobic Performance During a 30-s Wingate Test
This study investigates the acute effects of pre-exercise voluntary hyperventilation on pulmonary gas exchange, cardiovascular responses, and anaerobic performance during a 30-second Wingate test in athletic males using a randomized crossover design.
Read the detailed description
Background The purpose of this study was to examine how hyperventilation (HV) affected pulmonary gas exchange, cardiovascular responses, and supramaximal performance during a 30-second Wingate Anaerobic Test (WAnT).
Methods In a randomized crossover design, 18 athletic males completed both a control session and an HV session (30 breaths/min for 2 min prior to the WAnT).
- Conditions
- Anaerobic Performance
- Being tested
- Pre-exercise Voluntary Hyperventilation, Control Conditions
- Keywords
- Wingate Anaerobic Test, Respiratuar Alkalosis, Power Output, Fatigue
- Medical subject headings
- Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pre-exercise Voluntary HyperventilationOther
Participants performed voluntary hyperventilation at a rate of 30 breaths/min for 2 minutes prior to the 30-second Wingate anaerobic test.
Control ConditionsOther
Participants performed the 30-second Wingate test under control conditions without pre-exercise hyperventilation.
| Study group | Role | What they receive |
|---|---|---|
| Control Session | Active comparator | Participants performed the 30-second Wingate test under control conditions without pre-exercise hyperventilation Receives: Other: Control Conditions |
| Hyperventilation Session | Experimental | Participants performed voluntary hyperventilation (30 breaths/min for 2 min) prior to the 30-second Wingate test. Receives: Other: Pre-exercise Voluntary Hyperventilation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Peak Power Output and Mean Power Output during the 30-second Wingate test
Measured: During the 30-second Wingate test
Secondary outcomes (2)
Pulmonary Gas Exchange responses during the 30-second Wingate test (measured via COSMED Quark CPET system)
Measured: During the 30-second Wingate test
Heart Rate Responses during the 30-second Wingate test (measured via COSMED Quark CPET system)
Measured: During the 30-second Wingate test
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2026
- Study start11 Feb 2026
- Primary completion25 Feb 2026
- Study completion25 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anaerobic PerformanceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- Manisa Celal Bayar University
- Sponsor type
- University, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Responsible party
- Sponsor
- Investigators
- ERKAN GUNAY, Prof.Dr., Principal investigator, Manisa Celal Bayar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07797205
- Sponsor's protocol ID
- MCBU_324S917_HV
- Other IDs
- 324S917
- Status last verified
- Aug 2026
- First submitted
- 23 Aug 2026
- Last updated
- 1 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Yes, de-identified participant data will be shared upon reasonable request to the corresponding author.
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acute Effects of Pre-Exercise Voluntary Hyperventilation on Ventilatory Kinetics and Anaerobic Performance During a 30-s Wingate Test
- ClinicalTrials.gov ID
- NCT07797205
- Acronym / sponsor ID
- MCBU_324S917_HV
- Conditions
- Anaerobic Performance
- Keywords
- Wingate Anaerobic Test, Respiratuar Alkalosis, Power Output, Fatigue
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- Manisa Celal Bayar UniversityUniversity, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Study start
- 11 Feb 2026 (actual)
- Primary completion
- 25 Feb 2026 (actual)
- Study completion
- 25 Feb 2026 (actual)
- First posted
- 1 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the acute effects of pre-exercise voluntary hyperventilation on pulmonary gas exchange, cardiovascular responses, and anaerobic performance during a 30-second Wingate test in athletic males using a randomized crossover design.
Detailed description
Background The purpose of this study was to examine how hyperventilation (HV) affected pulmonary gas exchange, cardiovascular responses, and supramaximal performance during a 30-second Wingate Anaerobic Test (WAnT).
Methods In a randomized crossover design, 18 athletic males completed both a control session and an HV session (30 breaths/min for 2 min prior to the WAnT).
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control Session | Active comparator | Other: Control ConditionsParticipants performed the 30-second Wingate test under control conditions without pre-exercise hyperventilation |
| Hyperventilation Session | Experimental | Other: Pre-exercise Voluntary HyperventilationParticipants performed voluntary hyperventilation (30 breaths/min for 2 min) prior to the 30-second Wingate test. |
Who may qualify
- Ages
- 18 to 26 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Being a healthy male competitive athlete aged 18-26 years
- Having at least three years of consistent anaerobic training experience
- Being a nonsmoker
Key exclusion criteria (1 listed)
- Having any cardiovascular, musculoskeletal, neurological, or pulmonary disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pre-exercise Voluntary HyperventilationParticipants performed voluntary hyperventilation at a rate of 30 breaths/min for 2 minutes prior to the 30-second Wingate anaerobic test. | Other | Hyperventilation Session |
| Control ConditionsParticipants performed the 30-second Wingate test under control conditions without pre-exercise hyperventilation. | Other | Control Session |
Primary outcome
Peak Power Output and Mean Power Output during the 30-second Wingate test
Time frame: During the 30-second Wingate test
2 secondary outcomes
Pulmonary Gas Exchange responses during the 30-second Wingate test (measured via COSMED Quark CPET system)
Time frame: During the 30-second Wingate test
Heart Rate Responses during the 30-second Wingate test (measured via COSMED Quark CPET system)
Time frame: During the 30-second Wingate test
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2026.
- Individual participant dataSharing planned: Yes. Yes, de-identified participant data will be shared upon reasonable request to the corresponding author.
Related trials for Anaerobic Performance
Active, not recruiting
Effects of Blood Flow Restriction Training on Physical Function, Muscle Adaptations, and Performance in Roller Skaters
Athletic Performance Enhancement
Not yet recruitingObservational study
Pulmonary Function and Trunk Muscle Performance in Wrestlers
Pulmonary Function, Aerobic Performance
Not yet recruiting
SJFT Performance, Inhibitory Control, and Attention in Young Judokas
Cognitive Performance, Inhibitory Control
Not yet recruitingObservational study
Respiratory Muscle Strength and Jiu-Jitsu-Specific Performance in Male Brazilian Jiu-Jitsu Athletes
Athletic Performance
Not yet recruiting
The Effect of Individual Sodium Citrate Consumption on Repeated Sprint Performance in Female Soccer Players
Exercise-Induced Fatigue, Athletic Performance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ERKAN GUNAY, Prof.Dr. principal investigator
Manisa Celal Bayar University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pre-exercise Voluntary Hyperventilation in people with Anaerobic Performance, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Peak Power Output and Mean Power Output during the 30-second Wingate test (time frame: During the 30-second Wingate test). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.